Closed
SectorHealthcare
400.63 2.52
24h
Min
390.05
Max
401.42
Income | 387M 1B |
---|---|
Sales | 195M 3B |
P/E Sector Avg | 27.771 35.733 |
EPS | 4.06 |
Profit margin | 34.84 |
Employees | 6,100 |
EBITDA | 641M 1.4B |
Recommendations | Buy |
---|---|
12 Months Forecast | +25.91% upside |
Next Earnings | 3 lis 2025 |
---|
Market Cap | -21B 100B |
---|---|
Previous open | 398.11 |
Previous close | 400.63 |
By Acuity
54%
46%
308 / 371 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 492.35 USD 25.91%
High 624 USD
Low 405 USD
Based on 24 Wall Street analysts offering 12 month price targets forVertex Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$